Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

236.12
Delayed Data
As of Aug 28
 +1.22 / +0.52%
Today’s Change
111.41
Today|||52-Week Range
263.81
+64.99%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Operating ActivitiesNet Income / Starting Line276.7M508.1M74.5M-51.5M
 
 
 
 
 
Depreciation437.7M353.5M407.0M639.8M
 
 
 
 
 
Total Other Cash Flow-105.7M245.5M156.4M176.0M
 
 
 
 
 
Funds From Operations683.5M1.1B700.4M714.3M
 
 
 
 
 
Funds From/For Other Operating Expenses66.2M374.3M209.3M299.6M
 
 
 
 
 
Net Cash Flow - Operating Activities617.4M749.1M491.1M414.6M
 
 
 
 
 
 
InvestingIncrease In Investments249.7K-67.8M0.000.00
 
 
 
Decrease In Investments0.00125.6M17.7M159.1M
 
 
 
 
Capital Expenditures-39.1M-71.9M-65.8M-47.3M
 
 
 
 
 
Fixed Asset Disposal1.5B-32.1M----
 
 
 
Net Assets From Acquisitions -607.0M-88.8M-795.0M-13.2B
 
 
 
 
 
Other Investing - Uses0.000.00-10.3B10.3B
 
 
 
Other Investing - Sources----500.0K--
 
 
Net Cash Flow Investing760.3M-203.0M-11.2B-2.7B
 
 
 
 
 
 
FinancingShort Term Borrowings122.6K-2.0M0.000.00
 
 
 
Long Term Borrowings544.8M587.2M12.0B4.9B
 
 
 
 
 
Long Term Debt Reduction-1.6B-1.6B-1.1B-3.4B
 
 
 
 
 
Net Proceeds Stock Sale3.8M5.8M1.4B14.3M
 
 
 
 
 
Common Preferred Redeemed0.000.000.00-50.2M
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing15.9M-511.2K18.8M6.9M
 
 
 
 
 
Other Uses - Financing16.5M10.4M28.2M115.4M
 
 
 
 
 
Net Cash Flow - Financing-1.1B-1.0B12.3B1.4B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-15.3M-13.3M-15.1M2.9M
 
 
 
 
 
 
Net Change In Cash293.8M-465.8M1.6B-906.4M